RIL
BCRX icon

Rothschild Investment LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History

Rothschild Investment LLC’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Buy
867
+666
+331% +$6.02K ﹤0.01% 1973
2026
Q1 		$1.91K Sell
201
-1
-0.5% -$8 ﹤0.01% 2581
2025
Q4 		$1.58K Sell
202
-103
-34% -$745 ﹤0.01% 2487
2025
Q3 		$2.31K Sell
305
-80
-21% -$666 ﹤0.01% 2143
2025
Q2 		$3.45K Sell
385
-20
-5% -$186 ﹤0.01% 1695
2025
Q1 		$3.04K Buy
405
+155
+62% +$1.25K ﹤0.01% 1667
2024
Q4 		$1.88K Buy
250
+65
+35% +$493 ﹤0.01% 1839
2024
Q3 		$1.41K Buy
185
+75
+68% +$570 ﹤0.01% 1923
2024
Q2 		$680 Buy
110
+85
+340% +$469 ﹤0.01% 1854
2024
Q1 		$127 Buy
+25
New +$141 ﹤0.01% 2051

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Rothschild Investment LLC's BCRX Position: Q2 2026 in Review

Rothschild Investment LLC increased its BioCryst Pharmaceuticals (BCRX) stake by 331% in Q2 2026, buying an estimated $6.02K and bringing the position to 867 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Rothschild Investment LLC first reported a position in BCRX in Q1 2024 and has held it in 10 quarters since. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Rothschild Investment LLC held 867 shares of BioCryst Pharmaceuticals worth $8.67K as of Q2 2026.
  • Rothschild Investment LLC bought 666 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $6.02K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1973 holding.
  • Rothschild Investment LLC first reported a position in BioCryst Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.